Concept and viability of androgen annihilation for advanced prostate cancer

Publisher： John Wiley & Sons Inc

E-ISSN： 1097-0142|120|17|2628-2637

ISSN： 0008-543x

Source： CANCER, Vol.120, Iss.17, 2014-09, pp. : 2628-2637

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Intermittent Androgen Deprivation for Locally Advanced Prostate Cancer

By  

Oncology, Vol. 65, Iss. 1, 2003-09 ,pp. : 24-28

Karger

Access to resources Recommend Favorite

The predictive value of ERG protein expression for development of castration‐resistant prostate cancer in hormone‐naïve advanced prostate cancer treated with primary androgen deprivation therapy

By  

THE PROSTATE, Vol. 75, Iss. 14, 2015-10 ,pp. : 1499-1509

John Wiley & Sons Inc

Access to resources Recommend Favorite

Effects of Androgen Ablation Therapy in TRAIL Death Ligand and Its Receptors Expression in Advanced Prostate Cancer

By  

Urologia Internationalis, Vol. 84, Iss. 4, 2010-03 ,pp. : 445-451

Karger

Access to resources Recommend Favorite

Prescription Practice for LH-RH Analogs and Androgen Receptor Antagonists in the Treatment of Advanced Prostate Cancer in Germany (1993–2003)

By  

Urologia Internationalis, Vol. 77, Iss. 4, 2006-11 ,pp. : 311-316

Karger

Access to resources Recommend Favorite

Positive and negative mood in men with advanced prostate cancer undergoing androgen deprivation therapy: considering the role of social support and stress

By  

PSYCHO-ONCOLOGY (ELECTRONIC), Vol. 24, Iss. 8, 2015-08 ,pp. : 932-939

John Wiley & Sons Inc

Access to resources Recommend Favorite